EMEA-002114-PIP01-16

Key facts

Active substance
  • abacavir
  • lamivudine
  • efavirenz
Therapeutic area
Infectious diseases
Decision number
P/0191/2017
PIP number
EMEA-002114-PIP01-16
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Lek Pharmaceuticals d.d.
The Netherlands
Tel. +31 365241700
Fax +31 365232728
E-mail: caroline.kleinjan@sandoz.com

 
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating